Key facts
- Notable investors include NAVBharat.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Isera Biological
- ·The full record, as it builds
Funding rounds
No funding rounds for Isera Biological are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Isera Biological
Developer of molecular diagnostic technology designed for early disease detection and monitoring. The company's platform integrates proprietary biosensor chemistry with machine learning algorithms to analyse biological samples at the point of care, enabling healthcare providers improved diagnostic accuracy, faster clinical decision-making, and broader access to testing in decentralised settings
- Sector
- Healthcare
- HQ
- Pune, India
- Founded
- 2016
- Employees
- 33
- Website
- iserabio.com/
- Ownership
- Privately Held (backing)
Isera Biological doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Isera Biological shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Isera Biological in its N-PORT filings yet. We sweep new filings monthly.